Colibri Heart Valve
Manufacturing · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
486 S Pierce Ave Ste A, Louisville, Colo...Phone Number
(303) 460-8667Website
www.colibrihv.comRevenue
<$5 MillionIndustry
About Colibri Heart Valve
Colibri Heart Valve Org Chart
Is Colibri Heart Valve your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Colibri Heart Valve recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Colibri Heart Valve
Funding: Get notified immidiatlly once Colibri Heart Valve has new funding data
Website visits: Recent activity has been detected on your website
Check if Colibri Heart Valve has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Colibri Heart Valve launches new products
Colibri Heart Valve, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Colibri Heart Valve had a recent Job posting/layoffs
Check out if Colibri Heart Valve is spiking on competitors!
Recommended Actions
Find VP level buyers at Colibri Heart Valve
Find 3 more new buyers
Compare Similar Companies to Colibri Heart Valve
Compare insights from companies similar to Colibri Heart Valve, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Colibri Heart Valve is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Colibri Heart Valve is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Colibri Heart Valve.
Colibri Heart Valve financials insights
Gather financial insights about Colibri Heart Valve, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$1.4M
Private Equity
$4.9M
Debt
$750K
Private Equity
$1.3M
Colibri Heart Valve Tech Stack
A closer look at the technologies used by Colibri Heart Valve
Colibri Heart Valve News & Media
Colibri Heart Valve Initiates International CE Mark-enabling Pilot Study of Second-Generation TAVI System
LOUISVILLE, CO , Nov. 03, 2021 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced the initiation of an international pilot study of the Colibri transcatheter aortic valve implantation (TAVI) system. Bernard Chevalier, M.D., an interventional cardiologist at Hôpital Privé Jacques Cartier, is serving as primary investigator of the study. The study involves enrolling patients with severe aortic stenosis who are at high surgical risk. The fColibri Heart Valve Receives a United States Patent Directed to a Replacement Heart Valve that Includes a Dry Valve Sutured to a Stent Member
BROOMFIELD, CO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that U.S. Patent No. 10,390,945 (“the ‘945 Patent”) was issued on August 27, 2019 by the United States Patent & Trademark Office with a priority date extending back to July 2004. The ‘945 Patent has a total of ten claims, including a claim directed to a replacement heart valve that comprises a stent memberColibri Heart Valve to Present One-Year Patient Follow-Up Results from Clinical Feasibility Study of Second-Generation TAVI System at EuroPCR
BROOMFIELD, CO , May 14, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that results from the company’s international, single-arm, open-label early feasibility study (EFS) of the Colibri transcatheter aortic valve implantation (TAVI) system will be presented at the upcoming EuroPCR annual meeting taking place May 21-24, 2019. One-year follow-up data from the five evaluable patients, two of whom received a 27mm valve and three aGlobal Artificial Heart Valve Market - Technologies, Market Share and Industry Forecast to 2024: Huge Growth Opportunity in Emerging Economies - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Artificial Heart Valve Market- Technologies, Market share and Industry Forecast to 2024" report has been added to ResearchAndMarkets.com's offering. Global artificial heart valve market is expected to rise with the CAGR of about 12% during the forecast period. Emergence of MRI-conditional heart valves is the one of the key trend of the market. Key drivers fueling growth in the global market for artificial heart valve market are increasing geriatric populatio
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Colibri Heart Valve
Colibri Heart Valve is an emerging medical device company specializing in the development of the Colibri TAVI System, a unique transfemoral aortic heart valve that is pre-mounted and ready-for-use. The company focuses on innovative technologies that enhance the delivery and deployment of heart valves, utilizing a low profile balloon delivery system... Read More